These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6267246)
1. The inhibitory effect of propranolol pretreatment on its own metabolism in the rat. Schneck DW; Pritchard JF J Pharmacol Exp Ther; 1981 Sep; 218(3):575-81. PubMed ID: 6267246 [TBL] [Abstract][Full Text] [Related]
2. The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite. Pritchard JF; Schneck DW; Hayes AH Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):211-22. PubMed ID: 6768117 [TBL] [Abstract][Full Text] [Related]
3. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition. Marathe PH; Shen DD; Nelson WL Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280 [TBL] [Abstract][Full Text] [Related]
4. Systemic excretion of benzo(a)pyrene in the control and microsomally induced rat: the influence of plasma lipoproteins and albumin as carrier molecules. Shu HP; Bymun EN Cancer Res; 1983 Feb; 43(2):485-90. PubMed ID: 6293698 [TBL] [Abstract][Full Text] [Related]
5. Immunochemical study on the contributions of two molecular species of microsomal cytochrome P-450 to the metabolism of benzo(a)pyrene by rat liver microsomes. Hara E; Kawajiri K; Tagashira Y Cancer Res; 1983 Aug; 43(8):3604-8. PubMed ID: 6305488 [TBL] [Abstract][Full Text] [Related]
6. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate. Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177 [TBL] [Abstract][Full Text] [Related]
7. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo. Buckpitt AR; Warren DL J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280 [TBL] [Abstract][Full Text] [Related]
8. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450. Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709 [TBL] [Abstract][Full Text] [Related]
9. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation. Buckpitt AR; Bahnson LS; Franklin RB J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983 [TBL] [Abstract][Full Text] [Related]
10. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat. Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908 [TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
12. Modifications of microsomal and nuclear fractions by butylated hydroxyanisole and its effect on benzo(a)pyrene metabolites binding to macromolecules. Demkowicz-Dobrzański KK; Hennig EE; Juśkiewicz-Skiba M; Piekarski L Neoplasma; 1984; 31(4):423-30. PubMed ID: 6089009 [TBL] [Abstract][Full Text] [Related]
13. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Amato G; Longo V; Mazzaccaro A; Gervasi PG Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms. Daniel WA; Haduch A; Wójcikowski J Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279 [TBL] [Abstract][Full Text] [Related]
15. [Changes in testosterone oxidation in rat liver microsomes after prolonged administration of ethylmorphine]. Pospelova LN; Chistiakov VV Biokhimiia; 1981 Feb; 46(2):347-52. PubMed ID: 7248389 [TBL] [Abstract][Full Text] [Related]
16. Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. Danan G; Descatoire V; Pessayre D J Pharmacol Exp Ther; 1981 Aug; 218(2):509-14. PubMed ID: 7252850 [TBL] [Abstract][Full Text] [Related]
17. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378 [TBL] [Abstract][Full Text] [Related]
18. Covalent binding of procainamide in vitro and in vivo to hepatic protein in mice. Freeman RW; Uetrecht JP; Woosley RL; Oates JA; Harbison RD Drug Metab Dispos; 1981; 9(3):188-92. PubMed ID: 6166442 [TBL] [Abstract][Full Text] [Related]
20. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment. Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]